Cargando…
Serum IgE against galactose-alpha-1,3-galactose is common in Laotian patients with snakebite envenoming but not the major trigger for early anaphylactic reactions to antivenom
Snake antivenom is the only specific treatment for snakebite envenoming, but life-threatening anaphylaxis is a severe side effect and drawback for the use of these typically mammalian serum products. The present study investigates the hypotheses whether serum IgE antibodies against the epitope galac...
Autores principales: | Blessmann, Joerg, Hanlodsomphou, Soulaphap, Santisouk, Bounlom, Choumlivong, Khamla, Soukhaphouvong, Somphet, Chanthilat, Phankham, Brockow, Knut, Biedermann, Tilo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7393571/ https://www.ncbi.nlm.nih.gov/pubmed/32776003 http://dx.doi.org/10.1016/j.toxcx.2020.100054 |
Ejemplares similares
-
Situation of snakebite, antivenom market and access to antivenoms in ASEAN countries
por: Patikorn, Chanthawat, et al.
Publicado: (2022) -
Role and Mechanism of Galactose-Alpha-1,3-Galactose in the Elicitation of Delayed Anaphylactic Reactions to Red Meat
por: Hilger, Christiane, et al.
Publicado: (2019) -
Antivenoms for Snakebite Envenoming: What Is in the Research Pipeline?
por: Alirol, Emilie, et al.
Publicado: (2015) -
Cost-effectiveness of Antivenoms for Snakebite Envenoming in Nigeria
por: Habib, Abdulrazaq G., et al.
Publicado: (2015) -
The Need for Next-Generation Antivenom for Snakebite Envenomation in India
por: Vanuopadath, Muralidharan, et al.
Publicado: (2023)